Everything You Need to Know About the OIG Special Fraud Alert

The OIG’s Special Fraud Alert raised concerns towards some characteristics of speaker programs that may be considered risky. These programs, however, are necessary to educate healthcare professionals (HCPs) through Peer-to-Peer (P2P) educational strategies. When conducting P2P speaker programs, you can avoid some of the risks flagged by the OIG, and ensure that you are able to conduct successful educational programs. This page contains various resources to help you address your P2P marketing strategies going forward.

OIG Comparison
ARTICLE: How to Manage the Post-COVID-19 World of Speaker Programs after OIG’s New Special Fraud Alert

The COVID-19 pandemic has shown us how important the execution of successful virtual environments can be. In addition to being less expensive and more customized for HCPs, Virtual Speaker Programs also reduce the risks that were recently flagged by the OIG’s Special Fraud Alert. This blog post explains how to ensure that biopharma marketers are delivering educational information that adheres to the OIG’s guidelines.

VIDEO: Limiting Speaker Program Risks in Light of The OIG’s Special Fraud Alert

Speaker Programs provide tremendous value because they allow HCPs to learn important information to improve patient care through the collective experience of experts and colleagues in their fields. We did an internal analysis to determine how applicable the OIG’s guidance can be to Peer-to-Peer Speaker Programs, determining alternatives to modify programs and reduce risk. In this short video, V2V President Dan Rehal discusses the key factors to consider when conducting Speaker Programs and gets you up to speed in under 13 minutes.

ON-DEMAND WEBINAR: What to Do Now After OIG’s Special Fraud Alert 

Considering the concerns expressed in the OIG’s Special Fraud Alert, it is important to understand how to conduct speaker programs without increasing compliance risk. Watch V2V President Dan Rehal and biopharma industry experts Brian Dahl (Dahl Compliance Consulting) and Gary Mendelsohn (Astellas Pharma, U.S) as they dive into the future of speaker programs following the OIG’s guidance in this roundtable discussion. They discuss the impact of the alert on Speaker Bureaus, KOLs, HCPs and Healthcare Marketers, what can be done to limit an organization’s risk, and answer audience questions during a live Q&A session to provide actionable insights for P2P programs. WATCH NOW

ABOUT THE AUTHOR

Picture of Daniel J. Rehal

Daniel J. Rehal

As President of Vision2Voice, Daniel thoroughly understands the pharmaceutical industry from the ground floor up. By ascending the ranks at Merck to his global responsibilities at Takeda, Dan has significant experience in both marketing and sales roles supporting a multitude of pharmaceutical brands as an award-winning Sales Representative, Training Manager, District Manager, Senior Product Manager, and Marketing Director.

Recent Posts

Strategic Planning

Why You Must Do Strategic Planning for Next Year – Dan Recommends

I get how busy you are. You have direct reports with whom you need to work on their performance process. There are Key Opinion Leaders...

Read More
CS Spotlight - Lisa Dougherty

Client Services Spotlight – Creating Raving Fans

We recently sat down with Lisa Dougherty, V2V’s Vice President of Client Services, to discuss the value she and her team provide to BioPharma companies...

Read More
5 Details for Managing Speaker's Bureaus

5 Details You May Be Overlooking When Managing Your Speaker’s Bureau

Peer-to-peer works. This is why speakers remain one of the most important methods of engaging with your healthcare professionals (HCPs). It all starts with successful...

Read More